• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.15%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    106.62 Up 1.08(1.02%) 1:35PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:105.54
    Open:105.07
    Bid:106.94 x 300
    Ask:106.96 x 300
    1y Target Est:122.58
    Beta:1.18
    Earnings Date:Feb 3 - Feb 4 (Est.)
    Day's Range:104.87 - 107.77
    52wk Range:63.50 - 116.83
    Volume:5,920,121
    Avg Vol (3m):17,583,500
    Market Cap:160.85B
    P/E (ttm):19.00
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 1.02%160.85B
    GSKUp 0.71%108.97B
    PFEUp 0.80%206.09B
    RHHBYUp 0.45%N/A

    Key Statistics

    Forward P/E (1 yr):10.86
    P/S (ttm):7.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.89
    Quarterly EPS Est (Dec-14) :2.19
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback